drugset
drugset / Trial / NCT03880058

Safety and Efficacy of SLI-F06 in Wound Healing and Scar Appearance

NCT03880058 ↗

Phase 1/2 Completed 22 enrolled Scarless Laboratories, Inc. ethica Clinical Research Inc. · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

Multicenter, double-blind study comparing SLI-F06 to vehicle formulation buffer for the improvement in scar appearance and wound strength in routine surgical excisions, as well as post-operative abdominoplasty scar appearance.

Timeline

Start
2019-03-03
Primary completion
2021-05-18
Completion
2021-05-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator SLI-F06 Unknown — —

Indications

No indication recorded.